Jean‐Frédéric Blanc
Université de Bordeaux(FR)Inserm(FR)Inserm(FR)Institut Jules Bordet(BE)Centre Hospitalier Universitaire de Bordeaux(FR)Bordeaux Population Health(FR)Hôpital Saint-André(FR)Hôpital Cardiologique du Haut-Lévêque(FR)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Pancreatic and Hepatic Oncology Research, Liver Disease Diagnosis and Treatment, Cholangiocarcinoma and Gallbladder Cancer Studies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial(2018)2,497 cited
- → Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial(2023)936 cited
- → Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification(2017)753 cited
- → Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study(2013)593 cited
- → Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry(2007)586 cited
- →